Skip to main content
Clinical Trials/TCTR20200715001
TCTR20200715001
Completed
Phase 4

The effects of topical nasal steroids on continuous positive airway pressure compliance in patients with obstructive sleep apnea

Office of Research Development Phramongkutklao Hospital & Phramongkutklao College of Medicine0 sites80 target enrollmentStarted: July 15, 2020Last updated:

Overview

Phase
Phase 4
Status
Completed
Sponsor
Office of Research Development Phramongkutklao Hospital & Phramongkutklao College of Medicine
Enrollment
80

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 70 Years (—)
Sex
All

Inclusion Criteria

  • Inclusion criteria
  • 1\.Patient ranging in age from 18 to 70 years
  • 2\.Obstructive sleep apnea patient who were prescribed CPAP treatment by an ENT specialist
  • 3\.Patient with at least one nasal symptoms complaint such as rhinorrhea, nasal obstruction, nasal itching, and/or sneezing
  • 4\.Patient gave consent to be part of the study

Exclusion Criteria

  • Exclusion criteria
  • 1\.Patient refused to use CPAP device as a treatment for OSA
  • 2\.Patient refused to use topical nasal steroids
  • 3\.Patient had side effect from topical nasal steroids
  • 4\.Patient had received topical nasal steroids within 1 month prior to the study
  • 5\.Patient had lesion such as nasal septum deviation, nasal polyps, or unusual mass in their nostril
  • 6\.Patient had severe medical illness that could affect the treatment
  • 7\.Patient had a history of physical or mental abnormality that caused irregular sleep

Investigators

Sponsor
Office of Research Development Phramongkutklao Hospital & Phramongkutklao College of Medicine

Similar Trials